PLSE Operating Cash Flow Growth
Pulse Biosciences Inc · Operating Cash Flow Growth
PLSE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.31%period ending
PLSE TTM Cash from Operations YoY % (-226.80% → -37.31%)
Year-over-year change
High-resolution chart · PNG
PLSE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -37.3112% | |
| -37.7008% | |
| -48.92% | |
| -42.7844% | |
| -25.5601% | |
| -10.5918% | |
| -10.0136% | |
| 0.7276% | |
| -3.1104% | |
| 4.5908% | |
| 29.7322% | |
| 33.8564% | |
| 36.8913% | |
| 34.5062% | |
| 13.095% | |
| -2.1398% | |
| -18.7605% | |
| -54.9666% | |
| -52.9676% | |
| -43.4827% | |
| -32.069% | |
| -2.6126% | |
| -3.4518% | |
| -12.8095% | |
| -15.0421% | |
| -39.1827% | |
| -43.0574% | |
| -45.223% | |
| -66.5857% | |
| -92.6209% | |
| -115.5317% | |
| -128.2461% | |
| -126.277% | |
| -49.7139% | |
| -37.7096% | |
| -33.687% | |
| -32.8132% | |
| -110.2843% | |
| -142.7363% | |
| -226.8019% |